Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH is a protected peptide building block combining an Fmoc-protected glycine with a serine side chain bearing a Psi(Me,Me)pro substituent, forming a defined stereochemical and functional motif for peptide assembly. The molecule contains an Fmoc carbamate on the N-terminus, a free carboxylic acid at the C-terminus for coupling chemistry, and a serine hydroxyl that is masked by the Psi(Me,Me)pro group to control chemoselectivity during synthesis. The Psi(Me,Me)pro functionality introduces a sterically and electronically tuned side-chain protecting element that can be compatible with peptide synthesis conditions while enabling downstream transformation to reveal or further elaborate the serine-derived functionality. The presence of the glycine and serine backbone, together with the protected side chain, makes the compound suitable for constructing well-defined peptide analogs and for preparing stereochemically controlled intermediates for structure-focused synthetic studies.

1. Peptide Synthesis

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH supports solid-phase peptide synthesis workflows by providing an Fmoc-protected N-terminus for iterative coupling and a terminal carboxylic acid for activation-based amide bond formation. The glycine residue enables straightforward backbone incorporation, while the serine side chain is pre-organized with a Psi(Me,Me)pro-protected hydroxyl to suppress undesired side reactions during chain elongation. The Psi(Me,Me)pro group can be selected to withstand routine deprotection and coupling cycles, thereby improving control over orthogonal functional-group handling in multi-step peptide construction. Downstream, the resulting peptide products can be used as defined substrates or analogs where serine functionality is required at a later stage, aligning with amino acid derivative chemistry and peptide science needs.

2. Amino Acid Derivatization

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH functions as an amino acid derivative platform for side-chain functionalization strategies that depend on controlled hydroxyl availability. The serine hydroxyl is masked by the Psi(Me,Me)pro substituent, enabling selective downstream conversion after peptide assembly or during fragment elaboration using orthogonal deprotection logic. The Fmoc group and terminal carboxylic acid provide handles for sequential transformations, including N-deprotection for coupling, purification-compatible intermediate formation, and controlled release of reactive functionality. The compound can therefore be applied to synthesize serine-containing analogs where the side chain must be introduced, protected, and later converted into chemically distinct derivatives for subsequent synthetic or biochemical investigations.

3. Peptidomimetics And SAR Studies

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH can be employed in peptidomimetic construction where defined backbone geometry and protected side-chain chemistry are required to probe structure-activity relationship hypotheses. The glycine and serine framework enables incorporation into peptide-like scaffolds, while the Psi(Me,Me)pro substituent provides a consistent steric and electronic environment that can influence conformational preferences and intermolecular interactions. The protected hydroxyl allows preparation of analog series in which side-chain reactivity is introduced only after scaffold assembly, supporting systematic comparisons across closely related structures. The resulting peptide analogs and intermediates can serve as chemically defined inputs for SAR studies, fragment-based design campaigns, and molecular recognition experiments in applied medicinal chemistry research.

4. Chemical Biology Probes

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH is suitable for chemical biology research that requires serine-containing peptide motifs bearing controlled functional-group timing for probe generation. The Psi(Me,Me)pro-protected serine hydroxyl can be leveraged to delay installation of reactive groups until after conjugation-compatible steps, reducing cross-reactivity during probe synthesis. The Fmoc-protected amine and C-terminal carboxylic acid enable integration into peptide sequences used as labeling handles, affinity reagents, or biochemical assay components. Downstream, deprotection or side-chain conversion can furnish probes with defined attachment points, supporting reproducible biomolecule modification workflows and amino acid chemistry-driven probe design.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH can serve as a manufacturing-relevant intermediate for producing serine-containing peptide intermediates used in industrial fine chemical synthesis. The molecule's Fmoc-protected N-terminus supports standardized peptide coupling logic, while the terminal carboxylic acid provides a predictable site for activation and chain extension under controlled process conditions. The Psi(Me,Me)pro side-chain protection strategy supports chemoselective processing by limiting premature hydroxyl reactivity, which can reduce impurities from side reactions during scale-up-oriented synthesis planning. The compound's defined structure and protected functional groups enable consistent downstream conversion into peptide fragments and analogs that are compatible with process chemistry intermediate preparation and applied industrial peptide manufacturing workflows.

6. Analytical Research Standards

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH can be utilized to generate analytical standards and reference materials for method development in peptide and amino acid analysis. The presence of both an Fmoc-protected amine and a protected serine side chain yields a chemically stable signature that can be tracked by chromatographic and mass spectrometric methods during peptide synthesis monitoring. The terminal carboxylic acid and controlled side-chain protection help define fragmentation behavior and retention characteristics, supporting reproducible identification of coupling intermediates and protecting-group states. The compound can therefore support analytical research tasks including impurity profiling, process development characterization, and verification of protected amino acid incorporation in peptide building block preparation.

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling